Portfolio
SVLSFV closed in June 2010 with total commitments of $513m (plus $11 million of co-investments committed by partners and individuals affiliated with SVLS).
As at 31 December 2012 the Fund had invested $199m in 26 portfolio companies.
26 matching investments found
| Company | Country | Stage | Sector | Year |
|---|---|---|---|---|
 AcuFocus | US | Seed | Medical Devices Instrumentation | 2001 |
| AcuFocus, based in Irvine, CA, is developing an implantable corneal in-lay for the correction of presbyopia. | ||||
 AqueSys | US | Early Stage | Medical Devices Instrumentation | 2006 |
| AqueSys is based in Duluth, GA; AqueSys (TIF company) is developing an innovative approach to reducing intra-ocular pressure to treat glaucoma. | ||||
 Arsanis | US | Early Stage | Biotechnology Biopharmaceuticals | 2010 |
| Development of Monoclonal Antibodies to target infectious diseases. | ||||
 Autifony Therapeutics | UK | Early Stage | Biotechnology Biopharmaceuticals | 2011 |
| Focused on preclinical exploration and development of potential treatments for people with hearing disorders, including noise-induced hearing loss or tinnitus. | ||||
 Bicycle Therapeutics | UK | Seed | Biotechnology Biopharmaceuticals | 2009 |
| Developing a platform technology that may enable the creation of a new generation of biotherapeutics. | ||||
 Broadlane | US | Development | Healthcare Services | 2009 |
| Broadlane is a group purchasing organization ("GPO") focused on the acute care market. Broadlane provides technology-enabled services to assist hospitals in reducing supply costs and improve purchasing efficiency. | ||||
 Calchan Holdings | UK | Early Stage | Biotechnology Biopharmaceuticals | 2011 |
| Spin out from GSK. Focused on the development of novel analgesics with commercially attractive efficacy, responder-rate and side effect profiles | ||||
 CardioKinetix | US | Early Stage | Medical Devices Instrumentation | 2011 |
| Developing a device for treating Dilated cardiomyopathy (DCM)which causes one third of congestive heart failure cases. | ||||
 Catabasis Pharmaceuticals | US | Start Up | Biotechnology Biopharmaceuticals | 2010 |
| Developing therapeutics of the treatment of inflammatory and metabolic diseases. | ||||
 Cibiem (Formely Coridea NC1) | US | Seed | Medical Devices Instrumentation | 2010 |
| Coridea is a seed stage device company which is focusing on exploring possible treatments for diastolic heart failure, refractory angina and end-stage renal disease. | ||||
 Convergence Pharmaceuticals | UK | Early Stage | Biotechnology Biopharmaceuticals | 2010 |
| Spin out from GSK. Focused on the development of novel analgesics with commercially attractive efficacy, responder-rate and side effect profiles. | ||||
 CSA Medical | US | Early Stage | Medical Devices Instrumentation | 2011 |
| CSA Medical the leading developer of novel Spray Cryotherapy devices that freeze and destroy unwanted tissue inside the body. | ||||
 Cyterix Pharmaceuticals | US | Start Up | Biotechnology Biopharmaceuticals | 2011 |
| Cyterix is a start-up from UCSF and University of Dundee, focused on validating a broad platform to develop best in class anti-cancer agents. | ||||
 Good Start Genetics | US | Early Stage | Biotechnology Biopharmaceuticals | 2010 |
| Pre-pregnancy genetic testing business | ||||
 Health Essentials | US | Development | Healthcare Services | 2012 |
| A full-service healthcare organization that has been revolutionizing the delivery of post-acute care to the frail elderly. | ||||
 Homecare Homebase | US | Late Stage | Healthcare Services | 2011 |
| HCHB offers a comprehensive integrated web-based software solution to improve the clinical, operational and financial success of homecare and hospice agencies. | ||||
 Imagen Biotech | US | Start Up | Biotechnology Biopharmaceuticals | 2011 |
| Developing drugs for dry age related macular degeneration (AMD) | ||||
 Karus Therapeutics | UK | Early Stage | Biotechnology Biopharmaceuticals | 2012 |
| Karus Therapeutics is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer. | ||||
 Lux Biosciences | US | Seed | Biotechnology Biopharmaceuticals | 2006 |
| Lux is developing drugs for ophthalmic diseases. Their lead product is LX211, an oral drug for the treatment of uveitis. | ||||
 Nordic Consulting Partners | US | Development | Healthcare Services | 2012 |
| Nordic Consulting is a leading Healthcare IT (HIT) consulting firm focused exclusively on the implementation of Epic systems at healthcare providers. | ||||
 Rempex Pharmaceuticals | US | Start Up | Biotechnology Biopharmaceuticals | 2011 |
| Developing best in class antibiotics and potentiators to address the growing threat of resistance to existing treatment of infections. | ||||
 Sutro Biopharma, Inc | US | Early Stage | Biotechnology Biopharmaceuticals | 2006 |
| Sutro Biopharma's mission is to enable the production of low-cost, high quality rapidly developed protein pharmaceuticals and innovative vaccines that cannot be manufactured by existing technologies. Previously known as Fundamental Applied Biology's (FAB). | ||||
 The Corner Pharmacy | US | Development | Healthcare Services | 2010 |
| An owner and operator of hospital-based retail pharmacies through joint ventures with hospital systems. | ||||
 TopiVert | UK | Early Stage | Biotechnology Biopharmaceuticals | 2011 |
| Discovery and development of anti-inflammatory drugs for gastrointestinal and ophthalmic disorders. | ||||
 US Renal Care | US | Expansion | Healthcare Services | 2005 |
| US Renal Care(USRC) based in Dallas, TX, provides dialysis services to patients with end stage renal disease (ESRD) through the ownership and management of freestanding dialysis clinics. The company partners with local nephrologists in secondary markets underserved by dialysis consolidators. | ||||
 WellNow Urgent Care | US | Development | Healthcare Services | 2011 |
| An urgent care company focused on treating patients. Clinics offer you the convenience and expertise to treat everything that is non-life or limb threatening illness or injury while saving you time and money. | ||||